In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Amer. Cyanamid's Lederle Labs. merged w/ Immunex Corp.

Executive Summary

The oncology business of American Cyanamid's Lederle Laboratories (est. 1992 sales of $115 million) has merged with Immunex Corp. Cyanamid paid $380 million to Immunex shareholders for 53.3% of the new company, named Immunex.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Acquisition
    • Partial Acquisition

Related Companies